Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Survey finds London’s financial status will not be affected by AIFMD

Tuesday, July 24, 2012

Beverly Chandler, Opalesque London: A survey by compliance consultants the IMS Group has revealed that the alternatives industry is uncertain as to how the arrival of The Alternative Investment Fund Managers Directive (AIFMD) will impact on investment firms.

The survey was conducted among a group of 150 delegates at an IMS briefing on AIFMD. Findings included that with a year to go before its implementation, two fifths of the survey’s respondents (41%) were still assessing whether AIFMD would cause managers to make structural changes to their organisation. Further to this, 42% of respondents to the survey expected that AIFMD would influence their marketing strategies from 2013 onwards, 29% expected little influence and 23% didn’t expect any influence.

The survey came as news was announced that the publication of the final detail of the directive, which was slated for release on 22 July 2012, had been delayed, causing further uncertainty in the investment management industry.

IMS reported other findings that included:

  • 77% of respondents think regulatory developments such as AIFMD will have little or no impact on the attraction of London as a financial hub.
  • Capital requirements (19%) and risk management (21%) were highlighted as the top areas of concern for respondents within AIFMD, followed by depositary liability (14%) and remuneration (12%).
  • The largest negative impact of AIFMD is expected to be the ability to fundraise in Europe. Ho......................

    To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its